Myeloid derived suppressor cells are reduced and T regulatory cells stabilised in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega 3.

Isherwood, John; Arshad, Ali; Chung, Wen Yuan; Runau, Franscois; Cooke, Jill; Pollard, Cristina; Howells, Lynne; Fishwick, Jenny; Thompson, John; Metcalfe, Matthew; Steward, William; Dennison, Ashley

Isherwood, John; Arshad, Ali; Chung, Wen Yuan; Runau, Franscois; Cooke, Jill; Pollard, Cristina; Howells, Lynne; Fishwick, Jenny; Thompson, John; Metcalfe, Matthew; Steward, William; Dennison, Ashley.

Afiliação

Isherwood J; Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Leicester, UK.
Arshad A; Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Leicester, UK.
Chung WY; Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Leicester, UK.
Runau F; Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Leicester, UK.
Cooke J; Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Leicester, UK.
Pollard C; Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Leicester, UK.
Howells L; Leicester Cancer Research Centre, Leicester Royal Infirmary, Leicester, UK.
Fishwick J; Leicester Cancer Research Centre, Leicester Royal Infirmary, Leicester, UK.
Thompson J; Department of Health Sciences, University of Leicester, Leicester, UK.
Metcalfe M; Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Leicester, UK.
Steward W; Leicester Cancer Research Centre, Leicester Royal Infirmary, Leicester, UK.
Dennison A; Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Leicester, UK.